24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
State Lotteries Didn't Help Boost Vaccination RatesFDA Panel Recommends Approval of Johnson & Johnson Booster ShotHeart Defibs in Schools Are Saving Staff Lives: StudyHorseback Riding Carries Big Risk for Serious Injury: StudyTwo-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: PollAnother Study Finds Pfizer, Moderna Shots Effective Against COVID VariantsLyme Disease Often Spotted at Later Stage in Black PatientsFDA Panel Supports Moderna Booster Shot for Older Adults, People at High RiskIs a Really Bad Flu Season on the Way?Climate Change Could Bring Rising Obesity RatesKids Can Carry High, Infectious Levels of COVID CoronavirusMore Than Half of COVID-19 Survivors Will Get 'Long COVID'One-Third of Americans With Arthritis Get No ExerciseDeath Threats, Trolling Common for Scientists Who Speak to Media About COVIDAHA News: The Differences and Similarities Between the Flu and COVID-19FDA Questions Strength of Johnson & Johnson's Booster Shot DataHelmets Can Saves Lives in ATV, Dirt Bike CrashesCancer Care Costs U.S. $156 Billion Per Year; Drugs a Major FactorFDA Expert Panel to Weigh Approval of Moderna, Johnson & Johnson Booster ShotsAnti-Nausea Drug May Boost Survival for Some Cancer PatientsExpert Panel Backs Off Recommendation for Aspirin to Prevent Heart TroubleClot-Busting Drugs Safe in Stroke Patients When Brain Aneurysm Hasn't RupturedAccess to Top Drugs Makes the Difference for Black Lung Cancer PatientsRisk of COVID from Grocery Store Surfaces Very Low: Study60% of Americans Will Delay or Skip Flu Shot This Year: SurveyGolf Cart Injuries Keep Rising Among U.S. KidsMerck Asks FDA to Approve First COVID Antiviral PillWhen COVID Triggers Loss of Smell, Younger Patients Recover It SoonerSurgery Often a Gateway to Opioid Abuse, Study ConfirmsSymptomatic COVID Could Bring on Emergency Delivery in Pregnant WomenWhy Skin Cancer Checks Are Even More Important for Hispanic PeopleSocial Distancing Kept Kids From Getting Flu, RSVAir and Noise Pollution May Make You Vulnerable to Heart FailureCDC Urges Flu Shots as Survey Shows Half of Americans Don't Plan on ItPfizer Seeks FDA Emergency Approval for COVID Vaccine in Younger KidsCould an App Help Kids With Severe Ear Condition Avoid Surgery?1 in 7 Cancer Patients Worldwide Missed a Surgery Due to PandemicWestern Wildfires Are Making Easterners Sick: U.S. StudyStudies Show Power of Pfizer Vaccine Starts to Wane After Two MonthsJapanese Scientists Discover New Disease Carried by TicksOver 140,000 U.S. Children Have Lost a Caregiver to COVID-19Could Too Little Iron Boost Your Risk for Heart Disease?COVID Hospitalizations Are Rising Among Unvaccinated Pregnant WomenAs You Age, Your 'Microbiome' ChangesWHO Approves First Malaria Vaccine, a Lifesaver for Children WorldwideU.S. to Buy $1 Billion Worth of Rapid COVID Tests1 in 10 People Have Gastro Issues After a MealNearly 200,000 COVID Home Tests Recalled Over False PositivesBig Rise in Injuries From E-Scooters, HoverboardsStatins: Good for the Heart, Maybe Not So Good for Diabetes
Questions and AnswersLinks
Related Topics

Diabetes

U.S. to Buy $1 Billion Worth of Rapid COVID Tests

HealthDay News
by Robert Preidt and Robin Foster
Updated: Oct 6th 2021

new article illustration

WEDNESDAY, Oct. 6, 2021 (HealthDay News) -- The Biden administration said Wednesday that it plans to purchase $1 billion worth of rapid, at-home coronavirus tests and take other actions to quadruple the number of tests available to Americans by December.

By the end of the year, the number of at-home tests should increase to 200 million a month, according to the White House, which will also expand the number of pharmacies in the federal government's free testing program to 20,000, an administration official told the Washington Post.

Increasing access to rapid tests is long overdue, public health experts said.

"This is a big deal," Scott Becker, chief executive officer of the Association of Public Health Laboratories, told the Post. "The White House is beginning to take testing as seriously as they've taken vaccinations."

In recent months, many Americans have reported difficulty getting testing appointments or buying at-home tests, according to the Post.

"These tests are cheap to make -- and there's a lot of demand for it out there," Dr. Ashish Jha, dean of the Brown University School of Public Health, told the Post. "The reason the market hasn't worked is because the [U.S. Food and Drug Administration] has made it very difficult for these tests to get out into the marketplace."

One testing advocate said approvals of rapid tests are not coming fast enough.

"This slow trickle of [emergency authorizations] is all but promising to get us a large supply of rapid tests just in time for them to no longer be as effective against Delta," Dr. Michael Mina, a Harvard University epidemiologist who has advocated for at-home testing, told the Post. "There are amazing tests produced in the billions that simply don't exist here in the U.S."

FDA officials have said they are concerned that the rapid tests are less accurate than the slower PCR tests that need to be evaluated in a laboratory and can take days to produce results. On Wednesday, the Australian company Ellume recalled roughly 195,000 of its at-home coronavirus rapid tests after discovering an increased chance that the affected kits would return false positive results.

More information

Visit the U.S. Food and Drug Administration for more on COVID testing.

SOURCE: Washington Post